BIO-key International, Inc.
BKYI
$0.79
$0.0212.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.64% | -5.15% | -3.86% | 6.74% | 10.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.64% | -5.15% | -3.86% | 6.74% | 10.47% |
| Cost of Revenue | -79.61% | -45.29% | -8.03% | 54.94% | 159.21% |
| Gross Profit | 294.06% | 88.84% | 2.23% | -36.22% | -68.75% |
| SG&A Expenses | -10.50% | -15.62% | -20.30% | -17.04% | -14.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.02% | -24.50% | -18.00% | -4.54% | 10.13% |
| Operating Income | 54.56% | 40.65% | 28.67% | 13.85% | -9.83% |
| Income Before Tax | 50.05% | 56.57% | 50.19% | 40.74% | 27.45% |
| Income Tax Expenses | 82.84% | -326.14% | -325.94% | -556.86% | -556.86% |
| Earnings from Continuing Operations | 49.53% | 59.12% | 52.69% | 41.71% | 28.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.53% | 59.12% | 52.69% | 41.71% | 28.45% |
| EBIT | 54.56% | 40.65% | 28.67% | 13.85% | -9.83% |
| EBITDA | 56.97% | 43.69% | 30.36% | 15.25% | -9.12% |
| EPS Basic | 86.38% | 76.52% | 68.28% | 53.76% | 39.42% |
| Normalized Basic EPS | 87.19% | 66.79% | 55.54% | 38.30% | 16.48% |
| EPS Diluted | 86.38% | 76.52% | 68.28% | 53.76% | 39.42% |
| Normalized Diluted EPS | 87.19% | 66.79% | 55.54% | 38.30% | 16.48% |
| Average Basic Shares Outstanding | 283.20% | 175.92% | 124.93% | 77.90% | 19.02% |
| Average Diluted Shares Outstanding | 283.20% | 175.92% | 124.93% | 77.90% | 19.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |